THTien-Ming Hng

Tien-Ming Hng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tien-Ming Hng has a total of 144 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Type 2 diabetes remission following a comprehensive metabolic program including surgery in adults with BMI ≥50 kg/m 2 versus BMI 2

    by Xi May Zhen, Annette Macdonald, Benjamin Woodham, Brendan Ryan, Tien‐Ming Hng, Eileene Azar, Marina Hanna, Jesmine Yap, Jeenat Paulose, Guizhi Li, et al.

    Aims: Previous reports have suggested that higher baseline BMI (bBMI) or %excess weight loss (EWL) are independent predictors of type 2 diabetes mellitus (T2DM) remission after metabolic bariatric surgery (MBS). However, %EWL appears lower in individuals with bBMI ≥50 kg/m 2 than those with lower bBMI. Thus, this cohort study aimed to examine T2DM remission after MBS in adults with bBMI 2 versus bBMI ≥50 kg/m 2 . Methods: This cohort study included adults with obesity and T2DM who underwent MBS between 01/06/2018 and 31/05/2024 at an Australian tertiary hospital. The primary outcome was complete diabetes remission (HbA1c < 6.0%) at 12 months following MBS. Results: At 12 months following MBS, when compared to those with bBMI 2 , a higher proportion of patients with bBMI ≥50 kg/m 2 experienced complete diabetes remission (37.8% vs. 66.7%, 95% CI for the difference −48.5% to −6.3%, p = 0.014); this was no longer significant after adjustment for variables such as baseline T2DM duration and HbA1c. The bBMI ≥50 kg/m 2 group had greater total weight loss (kg) but lower %EWL, though neither was an independent predictor of remission. Conclusions: In our cohort, neither bBMI ≥50 kg/m 2 nor %EWL appeared as an independent predictor of T2DM remission. The higher proportion with remission (on unadjusted analyses) in those with bBMI ≥50 kg/m 2 potentially reflects less advanced diabetes despite greater obesity. Early consideration of MBS may be beneficial given that markers of diabetes duration/severity appeared as potentially important variables associated with T2DM remission.

  • Open Access

    Prediabetes: The Looming Burden for Australia

    by Gideon Meyerowitz‐Katz, Sarah N. Parry, Tien‐Ming Hng, N. Wah Cheung, Alice A. Gibson, Emily J. Hibbert, Kean‐Seng Lim, Eugen Molodysky, Glen Maberly, Louise A. Baur, et al.

    Diabetes is fast becoming the key health concern for Australia, with a substantial national increase in prevalence and an estimated 10% or more of adults living with the disease. Evidence shows that over half of this disease burden can be prevented by identifying prediabetes and providing appropriate interventions early. However, Australia currently has no accurate estimates of prediabetes prevalence, and no clear strategy on how to act when prediabetes is identified in clinical practice. This article lays out the problem, with potential solutions for government and the community.

  • Reply to Letter to the Editor ‘Three Additional Considerations for Interpreting HbA1c in Frail Older Adults With Diabetes’

    by Gideon Meyerowitz‐Katz, Julee McDonagh, Scott William, Reejamol John, Tien‐Ming Hng, Mark McLean, Mary Bul, Richard I. Lindley, Caleb Ferguson

  • Open Access

    The role of health literacy in medication adherence: Evidence from a greater western Sydney study of Indian migrants living with type 2 diabetes mellitus

    by Jinal Parmar, Kirsten McCaffery, Kh Shafiur Rahaman, Balwinder Sidhu, Dipti Zachariah, Tien-Ming Hng, Rajini Jayaballa, Vincent Wong, Emily Hibbert, Una Turalic, et al.

  • Open Access

    A Pragmatic Cluster-Randomized Trial of Insulin Therapy for Dexamethasone-Induced Hyperglycemia Amongst Diabetes Patients with COVID-19

    by Ngai Wah Cheung, Amanda Hor, Simone Marschner, Christopher Chan, Haeri Min, Lauren Lee, Tien-Ming Hng, Yoon Ji Jina Rhou, Yu-Fang Wu, Mawson Wang, et al.

    Background: Glucocorticoid-induced hyperglycemia is common amongst hospitalized patients. Isophane insulin has been proposed as part of the optimal insulin regimen for managing this, but there are few randomized controlled trials to support this. Our aim was to determine if the addition of a morning dose of isophane insulin would improve glycemic control amongst patients with COVID-19 who had dexamethasone-induced hyperglycemia (DIH) in hospital. Methods: Patients with diabetes admitted to hospital with COVID-19 respiratory infection and treated with dexamethasone were cluster-randomized by ward to receive either basal bolus insulin (BBI) or isophane-augmented BBI (IaBBI) in equipotent doses. Insulin commencement and titration were guided by standardized protocols. The primary outcome was overall finger-prick blood glucose (BG) levels, with predefined secondary outcomes of BGs on day 3 and the final day of admission. Results: A total of 40 patients were included, 25 in the IaBBI group and 15 in the BBI only group, for a duration of 5.4 ± 2.2 days. Both recruitment and the trial were terminated early because of a rapid decline in COVID-19 admissions. There were no differences in overall mean BG levels (IaBBI 11.9 ± 2.5 mmol/L vs. BBI 12.6 ± 2.4 mmol/L, p = 0.193) between the groups. Mean day 3 BGs were lower in the IaBBI group than in the BBI group (11.1 ± 3.5 mmol/L vs. 12.7 ± 3.5 mmol/L, p = 0.029) and on the final day (9.6 ± 2.8 mmol/L vs. 10.7 ± 2.5 mmol/L, respectively, p = 0.011). Conclusions: The restricted sample size in this study limits any conclusions that can be made regarding the effectiveness of the addition of isophane insulin to a BBI insulin regimen for diabetes patients with COVID-19 infection and DIH. However, some improvements in glycemic control were observed, suggesting that this is a glucose management strategy that warrants further evaluation.

  • Open Access

    Surveillance for Diabetes in Hospital-Evaluation of Dashboard Effectiveness

    by Tien-Ming Hng, Reshma Kolambkar, Ching Luo, David Pryce

    There is a large burden of diabetes in Western Sydney, and this descriptor is also valid for the inpatient population. Optimizing diabetes care in hospital is important to prevent inpatient morbidity. A surveillance system was developed to address this need and a diabetes dashboard was developed around a data model built around the patient journey that integrated key data feeds from the pathology, medication, and patient administration systems. This facilitated the rapid identification and triaging of individuals with diabetes. We evaluated this dashboard using high level clinical and financial indicators. This implementation resulted in an improved time to patient review, and a reduction in 28-day readmission rates but the inpatient length of hospital stay was unchanged. (116 words).


  • Open Access

    Effect of Mobile Phone Text Messaging Self-Management Support for Patients With Diabetes or Coronary Heart Disease in a Chronic Disease Management Program (SupportMe) on Blood Pressure: Pragmatic Randomized Controlled Trial

    by Ngai Wah Cheung, Julie Redfern, Aravinda Thiagalingam, Tien-Ming Hng, Simone Marschner, Rabbia Haider, Sonia Faruquie, Amy Von Huben, Shelley She, Daniel McIntyre, et al.

    Background: Maintaining engagement and support for patients with chronic diseases is challenging. SMS text messaging programs have complemented patient care in a variety of situations. However, such programs have not been widely translated into routine care. Objective: We aimed to examine the implementation and utility of a customized SMS text message–based support program for patients with type 2 diabetes (T2D), coronary heart disease, or both within a chronic disease integrated care program. Methods: We conducted a 6-month pragmatic parallel-group, single-blind randomized controlled trial that recruited people with T2D or coronary heart disease. Intervention participants received 4 semipersonalized SMS text messages per week providing self-management support to supplement standard care. Preprogrammed algorithms customized content based on participant characteristics, and the messages were sent at random times of the day and in random order by a fully automated SMS text messaging engine. Control participants received standard care and only administrative SMS text messages. The primary outcome was systolic blood pressure. Evaluations were conducted face to face whenever possible by researchers blinded to randomization. Participants with T2D were evaluated for glycated hemoglobin level. Participant-reported experience measures were evaluated using questionnaires and focus groups and summarized using proportions and thematic analysis. Results: A total of 902 participants were randomized (n=448, 49.7% to the intervention group and n=454, 50.3% to the control group). Primary outcome data were available for 89.5% (807/902) of the participants. At 6 months, there was no difference in systolic blood pressure between the intervention and control arms (adjusted mean difference=0.9 mm Hg, 95% CI −1.1 to 2.1; P=.38). Of 642 participants with T2D, there was no difference in glycated hemoglobin (adjusted mean difference=0.1%, 95% CI −0.1% to 0.3%; P=.35). Self-reported medication adherence was better in the intervention group (relative risk=0.82, 95% CI 0.68-1.00; P=.045). Participants reported that the SMS text messages were useful (298/344, 86.6%) and easily understood (336/344, 97.7%) and motivated change (217/344, 63.1%). The lack of bidirectional messaging was identified as a barrier. Conclusions: The intervention did not improve blood pressure in this cohort, possibly because of high clinician commitment to improved routine patient care as part of the chronic disease management program as well as favorable baseline metrics. There was high program engagement, acceptability, and perceived value. Feasibility as part of an integrated care program was demonstrated. SMS text messaging programs may supplement chronic disease management and support self-care. Trial Registration: Australian New Zealand Clinical Trials Registry ACTRN12616001689460; https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=371769&isReview=true International Registered Report Identifier (IRRID): RR2-10.1136/bmjopen-2018-025923


  • Open Access

    Effect of Mobile Phone Text Messaging Self-Management Support for Patients With Diabetes or Coronary Heart Disease in a Chronic Disease Management Program (SupportMe) on Blood Pressure: Pragmatic Randomized Controlled Trial (Preprint)

    by Ngai Wah Cheung, Julie Redfern, Aravinda Thiagalingam, Tien-Ming Hng, Simone Marschner, Rabbia Haider, Sonia Faruquie, Amy Von Huben, Shelley She, Daniel McIntyre, et al.

    BACKGROUND Maintaining engagement and support for patients with chronic diseases is challenging. SMS text messaging programs have complemented patient care in a variety of situations. However, such programs have not been widely translated into routine care. OBJECTIVE We aimed to examine the implementation and utility of a customized SMS text message–based support program for patients with type 2 diabetes (T2D), coronary heart disease, or both within a chronic disease integrated care program. METHODS We conducted a 6-month pragmatic parallel-group, single-blind randomized controlled trial that recruited people with T2D or coronary heart disease. Intervention participants received 4 semipersonalized SMS text messages per week providing self-management support to supplement standard care. Preprogrammed algorithms customized content based on participant characteristics, and the messages were sent at random times of the day and in random order by a fully automated SMS text messaging engine. Control participants received standard care and only administrative SMS text messages. The primary outcome was systolic blood pressure. Evaluations were conducted face to face whenever possible by researchers blinded to randomization. Participants with T2D were evaluated for glycated hemoglobin level. Participant-reported experience measures were evaluated using questionnaires and focus groups and summarized using proportions and thematic analysis. RESULTS A total of 902 participants were randomized (n=448, 49.7% to the intervention group and n=454, 50.3% to the control group). Primary outcome data were available for 89.5% (807/902) of the participants. At 6 months, there was no difference in systolic blood pressure between the intervention and control arms (adjusted mean difference=0.9 mm Hg, 95% CI −1.1 to 2.1; P=.38). Of 642 participants with T2D, there was no difference in glycated hemoglobin (adjusted mean difference=0.1%, 95% CI −0.1% to 0.3%; P=.35). Self-reported medication adherence was better in the intervention group (relative risk=0.82, 95% CI 0.68-1.00; P=.045). Participants reported that the SMS text messages were useful (298/344, 86.6%) and easily understood (336/344, 97.7%) and motivated change (217/344, 63.1%). The lack of bidirectional messaging was identified as a barrier. CONCLUSIONS The intervention did not improve blood pressure in this cohort, possibly because of high clinician commitment to improved routine patient care as part of the chronic disease management program as well as favorable baseline metrics. There was high program engagement, acceptability, and perceived value. Feasibility as part of an integrated care program was demonstrated. SMS text messaging programs may supplement chronic disease management and support self-care. CLINICALTRIAL Australian New Zealand Clinical Trials Registry ACTRN12616001689460; https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=371769&isReview=true INTERNATIONAL REGISTERED REPORT RR2-10.1136/bmjopen-2018-025923

  • Open Access

    The impact of type 1 diabetes mellitus in childhood on academic performance: A matched population‐based cohort study

    by Rebecca J. Mitchell, Anne McMaugh, Helen Woodhead, Reidar P. Lystad, Yvonne Zurynski, Tim Badgery‐Parker, Cate M. Cameron, Tien‐Ming Hng

    Background The impact of type 1 diabetes mellitus (T1D) on academic performance is inconclusive. This study aims to compare scholastic performance and high school completion in young people hospitalised with T1D compared to matched peers not hospitalised with diabetes. Method A population-level matched case-comparison study of people aged ≤18 hospitalised with T1D during 2005-2018 in New South Wales, Australia using linked health-related and education records. The comparison cohort was matched on age, gender and residential postcode. Generalised linear mixed modelling examined risk of school performance below the national minimum standard (NMS) and generalised linear regression examined risk of not completing high school for young people hospitalised with T1D compared to peers. Adjusted relative risks (ARR) were calculated. Results Young females and males hospitalised with T1D did not have a higher risk of not achieving the NMS compared to peers for numeracy (ARR: 1.19; 95%CI 0.77-1.84 and ARR: 0.74; 95%CI 0.46-1.19) or reading (ARR: 0.98; 95%CI 0.63-1.50 and ARR: 0.85; 95%CI 0.58-1.24), respectively. Young T1D hospitalised females had a higher risk of not completing year 11 (ARR: 1.73; 95%CI 1.19-2.53) or 12 (ARR: 1.65; 95%CI 1.17-2.33) compared to peers, while hospitalised T1D males did not. Conclusions There was no difference in academic performance in youth hospitalised with T1D compared to peers. Improved glucose control and T1D management may explain the absence of school performance decrements in students with T1D. However, females hospitalised with T1D had a higher risk of not completing high school. Potential associations of this increased risk, with attention to T1D and psycho-social management, should be investigated.